Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$165.67 - $199.94 $835,473 - $1.01 Million
5,043 New
5,043 $853,000
Q2 2022

Aug 03, 2022

SELL
$155.97 - $200.09 $1.98 Million - $2.54 Million
-12,695 Closed
0 $0
Q1 2022

Apr 26, 2022

BUY
$181.39 - $234.03 $2.3 Million - $2.97 Million
12,695 New
12,695 $2.38 Million
Q3 2021

Oct 21, 2021

SELL
$189.29 - $209.69 $755,267 - $836,663
-3,990 Closed
0 $0
Q2 2021

Jul 28, 2021

BUY
$155.9 - $187.99 $137,347 - $165,619
881 Added 28.34%
3,990 $788,000
Q1 2021

May 12, 2021

SELL
$144.0 - $169.39 $381,744 - $449,052
-2,651 Reduced 46.02%
3,109 $499,000
Q4 2020

Feb 04, 2021

BUY
$157.07 - $174.35 $441,680 - $490,272
2,812 Added 95.39%
5,760 $963,000
Q3 2020

Nov 02, 2020

SELL
$137.1 - $165.37 $1.09 Million - $1.31 Million
-7,935 Reduced 72.91%
2,948 $497,000
Q2 2020

Jul 29, 2020

BUY
$111.92 - $142.53 $1.22 Million - $1.55 Million
10,883 New
10,883 $1.52 Million
Q4 2019

Jan 16, 2020

SELL
$116.25 - $133.25 $639,375 - $732,875
-5,500 Closed
0 $0
Q3 2019

Oct 31, 2019

SELL
$112.57 - $128.43 $782,361 - $892,588
-6,950 Reduced 55.82%
5,500 $715,000
Q2 2019

Aug 08, 2019

BUY
$97.98 - $114.28 $1.22 Million - $1.42 Million
12,450 New
12,450 $1.44 Million
Q4 2018

Feb 14, 2019

SELL
$79.28 - $95.27 $864,865 - $1.04 Million
-10,909 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$83.5 - $93.23 $471,274 - $526,190
5,644 Added 107.2%
10,909 $987,000
Q2 2018

Aug 14, 2018

BUY
$79.9 - $89.2 $420,673 - $469,638
5,265 New
5,265 $450,000
Q1 2018

May 15, 2018

SELL
$71.51 - $84.69 $921,406 - $1.09 Million
-12,885 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$63.24 - $72.8 $814,847 - $938,028
12,885 New
12,885 $993,000
Q3 2017

Nov 14, 2017

SELL
$59.73 - $65.4 $987,993 - $1.08 Million
-16,541 Closed
0 $0
Q2 2017

Aug 14, 2017

BUY
N/A
16,541
16,541 $1.03 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Sciencast Management LP Portfolio

Follow Sciencast Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sciencast Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Sciencast Management LP with notifications on news.